hotspot -WSS

hotspot

author：fashion 2025-08-11 07:58:31 - browse：7

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

hotspot

WSS

Hospitals look to new technology to keep health care workers safe

Anthos stroke drug appears safer than common blood thinner

U.K. considers world's first use of meningitis vaccine to address gonorrhea

A pediatrician calls for Congress to pass the child tax credit deal

FDA endorses new sterilization method for medical devices

Dog Aging Project founders on what lies ahead after losing funding

explore

hotspot

Wikipedia

Virginia high school admissions case could be legal follow

In key trial, Verve's treatment lowers cholesterol levels in patients

Virginia high school admissions case could be legal follow

Cardiologists urge adding sexual orientation, gender identity to health records

Wildfire smoke exposes gaps in outdoor worker protections

Poor hospice wound care hurts patients and families

BioMarin wins approval for gene therapy to treat hemophilia A

To bolster infectious disease surveillance, genomics powerhouses team up

Affirmative action in medical school literally saved lives

David Sabatini, ex

Wikipedia

Why medical students are struggling with mental health

HPV vaccine, cervical cancer study delivers historic results

World's first CRISPR

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Maisha Meds is a PBM, but don't call it that

Congress must reauthorize a committee to support older Americans

entertainment

hotspot

leisure time

focus